A primate model of schizophrenia using chronic PCP treatment

Can Van Mao, Etsuro Hori, Rafael Maior, Taketoshi Ono, Hisao Nishijo*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

To establish a primate animal model of schizophrenia with negative symptoms, the behavioral effects of chronic phencyclidine (PCP) and additional acute methamphetamine (MAP) administration were investigated in six monkeys. The results indicate that chronic PCP treatment induced a significant decrease in all categories of social behaviors, and that the chronic PCP monkeys also spent less time in proximity to other monkeys than the control monkeys. Acute MAP injection to the chronic PCP monkeys exacerbated the behavioral effects of PCP. The results suggest that these monkeys can be used as a primate model of schizophrenia with negative symptoms.

Original languageEnglish
Pages (from-to)83-89
Number of pages7
JournalReviews in the Neurosciences
Volume19
Issue number2-3
StatePublished - 2008

Keywords

  • Methamphetamine
  • Monkey
  • Negative symptoms
  • Phencyclidine
  • Schizophrenia
  • Social behaviors

ASJC Scopus subject areas

  • General Neuroscience

Fingerprint

Dive into the research topics of 'A primate model of schizophrenia using chronic PCP treatment'. Together they form a unique fingerprint.

Cite this